Skip to main content

Radiation oncology workforce examine shows potential risk to provincial cancer growth care access

The latest study from America’s Radiation Oncology shows that gender and race gaps got narrowed. The survey from Radiation oncology physicians shows that more than 1100 physicians are in the all over the country and only a few physicians are practicing in the rural areas.

Research from the American Society for Radiation Oncology shows the graphic summarizing results.
Few of the examples that the study includes:

 Migration of physicians from rural to the urban area:
According to the survey 9 Radiation Oncologist out of 10 works in the urban area and the surveys also show that the proportion of the oncologist in the rural area got decreased. The amount of rural radiation oncologist got decreased from 16% into 13% and it leads to making problem in accessing the Radiation therapy services.

In order to overcome this ASTRO is focusing more on providing the radiation oncology services to the rural areas.

Almost 60 million American people live in rural areas and everyone wants to get the medical care services near to their home. Because of this problem always there will be a difference between being treated and not being treated.

 Gender equity movement:
Considering the previous survey, the female radiation oncologist percentage got increased from 26% into 29%. Nowadays women are very common in all kind of workforces. The modest but noticeable increases in the number of women and racial/ethnic minorities, for example, indicate that our field is moving toward more equity.

 Moving to Academic centers from private practice:
Generally, most of the Radiation Oncologists are working for treating patients primarily in private practices, Academic centers, and hospitals. Survey of 2017 shows that few of the radiation oncologists are working in private practices with practicing at the academic universities and some are working in non-academic hospitals.

 Increasing the availability of new technology:
95% of practices are often providing treatments to patients without increasing the risk of side effects. For most of the tumors, hypofractionation(i.e. Radiation therapy is given over a shorter period of time (fewer days or weeks) than standard radiation therapy) is the main treatment such as breast tumor, brain tumor. Nowadays some clinics are also getting adapted to the advanced technologies for providing better treatment with the low risk of side effects.

ASTRO is currently conducting various workforce studies to find recent trends and also increasing the employment and new technology used to access patient needs. The survey was conducted in 2017 and it reflects the response from almost 1174 oncologist representing 726 practices. 

Get to know about more such insights in our next event which is scheduled to be held at Rome, Italy on May 20-21, 2019. To know more about this event visit: Cancer Conference 2019

To book your speaker slot at the conference, register here at Cancer Conference registration

Courtesy: www.eurekalert.org

Keywords:
Cancer | Oncology | Cancer conferences | oncology events | Cancer insights
Labels:

Comments

Post a Comment

Popular posts from this blog

Poster Presentation - Influence of NECC (Nutrition and Exercise Center for Cancer Patients) on survival and body composition in Gastrointestinal Cancer Patients

Abstract BACKGROUND : Gastrointestinal cancer patients are particularly predisposed to develop cancer cachexia. Cachectic patients are characterized by loss of adipose tissue as well as skeletal muscle wasting which has a tremendous impact on quality of life and survival (1, 4). In terms of improvement for this multifactorial syndrome, Klinikum rechts der Isar (MRI) in Munich, Germany has founded NECC, a treatment concept including nutrition intervention and an individual training program. METHODS : In this study we focused on patients with pancreatic (n =15) and upper gastrointestinal cancer (n = 21). Body composition using CT images was analyzed initially, 4 weeks, 3 months and 6 months after initial visit of NECC (Image 1). To underline the outcome, NECC patients were matched to adequate partners who correspond in age, gender, diagnosis with TNM classification and type of surgery. The control group does not receive any further support concerning nutrition and physical exercise...
2 comments
Read more

Poster Presentation - Reactive carbonyl compounds of protein in patients’ blood after surgical treatment of breast cancer

Abstract Introduction . The problem of breast cancer (BC) is one of the important and complicated in oncology. In this aspect, there is a significant amount of interest in the study of oxidative processes, since their disorders can act as one of the pathogenetic factors of carcinogenesis. Aim of the study . To study the Reactive carbonyl compounds of proteins (RCCs) in plasma and in erythrocytes of blood of the BC patients after surgical treatment. Materials and methods . The blood of 20 women with BC was examined, which have I-IIIa stages after surgical treatment in the volume of radical resection or radical mastectomy performed at the first stage of treatment. The control group consisted of practically healthy women (n = 15). The level RCCs in erythrocytes and in blood plasma was determined by the method of Levine R.L et al. (1990). Results of the study . In erythrocytes of BC patients with I stage, there was a slight decrease in the percentage of RCCs. At the same...
Post a Comment
Read more

Past Conference Report - Cancer Research

With great support from our Collaborators and Organizing Committee, PULSUS Conferences successfully completed the “Cancer 2018” which was held at Edinburgh, Scotland on March 26-27, 2018. We would like to thank our Keynote Speakers for the conference - Hiroshi Kobayashi , Chiba University, Japan, William T. Beck , University of Illinois, USA, Shalini Gupta , King George Medical College, India, Antonio Gomez-Munoz , University Of The Basque Country, Spain, Barbara DeVivo , Westmont University, USA. for their support in making this event a great success. We would like to extend our thanks to our collaborators “ Sudanese Medical Research Association ”, “ Uganda Cancer Society ” and “ Pharmaceutical Society of Uganda ” for their constant support. It wouldn’t have been possible without the support of our Media Partners who helped us in promoting this event. We thank our Media partners for their support in helping us reach a greater audience. We also would like to thank all o...
Post a Comment
Read more